Upexi Inc (UPXI)

$2.41

-0.21

(-8.02%)

Market is closed - opens 7 PM, 10 Oct 2024

Performance

  • $2.27
    $2.80
    $2.41
    downward going graph

    5.78%

    Downside

    Day's Volatility :18.92%

    Upside

    13.95%

    downward going graph
  • $2.17
    $36.56
    $2.41
    downward going graph

    9.96%

    Downside

    52 Weeks Volatility :94.06%

    Upside

    93.41%

    downward going graph

Returns

PeriodUpexi IncIndex (Russel 2000)
3 Months
-66.42%
0.0%
6 Months
-74.81%
0.0%
1 Year
-92.01%
0.0%
3 Years
-97.42%
-20.8%

Highlights

Market Capitalization
2.7M
Book Value
$21.1
Earnings Per Share (EPS)
-1.23
Wall Street Target Price
25.0
Profit Margin
-27.72%
Operating Margin TTM
-34.18%
Return On Assets TTM
-9.22%
Return On Equity TTM
-78.65%
Revenue TTM
84.0M
Revenue Per Share TTM
83.43
Quarterly Revenue Growth YOY
-34.0%
Gross Profit TTM
33.6M
EBITDA
-3.7M
Diluted Eps TTM
-1.23
Quarterly Earnings Growth YOY
35.73
EPS Estimate Current Year
-9.8
EPS Estimate Next Year
-6.8
EPS Estimate Current Quarter
-2.2
EPS Estimate Next Quarter
-1.8

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 6 Wall street analysts offering stock ratings for Upexi Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
6
Hold
3
3
1
Sell
3
3
00

Analyst Forecast

What analysts predicted

Upside of 937.34%

Current $2.41
Target $25.00

Company Financials

FY19Y/Y Change
Revenue
2.2M
-
Net Income
-585.0K
-
Net Profit Margin
-26.5%
-
FY20Y/Y Change
Revenue
7.4M
↑ 235.72%
Net Income
-5.9M
↑ 913.67%
Net Profit Margin
-80.0%
↓ 53.5%
FY21Y/Y Change
Revenue
24.1M
↑ 225.04%
Net Income
3.0M
↓ 150.23%
Net Profit Margin
12.36%
↑ 92.36%
FY22Y/Y Change
Revenue
44.6M
↑ 85.04%
Net Income
-2.0M
↓ 168.68%
Net Profit Margin
-4.59%
↓ 16.95%
FY23Y/Y Change
Revenue
80.7M
↑ 80.95%
Net Income
-16.9M
↑ 727.47%
Net Profit Margin
-20.99%
↓ 16.4%
Q1 FY23Q/Q Change
Revenue
24.2M
↓ 10.59%
Net Income
-2.1M
↓ 177.04%
Net Profit Margin
-8.49%
↓ 18.35%
Q2 FY23Q/Q Change
Revenue
17.8M
↓ 26.45%
Net Income
-15.4M
↑ 646.72%
Net Profit Margin
-86.22%
↓ 77.73%
Q3 FY23Q/Q Change
Revenue
27.3M
↑ 53.52%
Net Income
-1.4M
↓ 91.17%
Net Profit Margin
-4.96%
↑ 81.26%
Q4 FY23Q/Q Change
Revenue
21.8M
↓ 20.18%
Net Income
-2.4M
↑ 79.74%
Net Profit Margin
-11.17%
↓ 6.21%
Q1 FY24Q/Q Change
Revenue
14.4M
↓ 33.82%
Net Income
-4.1M
↑ 68.94%
Net Profit Margin
-28.51%
↓ 17.34%
Q2 FY24Q/Q Change
Revenue
14.4M
↑ 0.0%
Net Income
-4.1M
↑ 0.0%
Net Profit Margin
-28.51%
↑ 0.0%
FY19Y/Y Change
Total Assets
7.5M
-
Total Liabilities
1.1M
-
FY20Y/Y Change
Total Assets
6.4M
↓ 14.68%
Total Liabilities
4.2M
↑ 281.27%
FY21Y/Y Change
Total Assets
27.3M
↑ 325.71%
Total Liabilities
6.0M
↑ 42.95%
FY22Y/Y Change
Total Assets
48.5M
↑ 77.92%
Total Liabilities
19.7M
↑ 226.41%
FY23Y/Y Change
Total Assets
63.9M
↑ 31.68%
Total Liabilities
36.0M
↑ 82.78%
Q1 FY23Q/Q Change
Total Assets
73.8M
↓ 3.68%
Total Liabilities
37.1M
↓ 7.04%
Q2 FY23Q/Q Change
Total Assets
63.9M
↓ 13.5%
Total Liabilities
36.0M
↓ 2.88%
Q3 FY23Q/Q Change
Total Assets
65.2M
↑ 2.18%
Total Liabilities
37.7M
↑ 4.61%
Q4 FY23Q/Q Change
Total Assets
62.2M
↓ 4.73%
Total Liabilities
36.7M
↓ 2.59%
Q1 FY24Q/Q Change
Total Assets
56.5M
↓ 9.09%
Total Liabilities
34.5M
↓ 6.12%
Q2 FY24Q/Q Change
Total Assets
56.5M
↑ 0.0%
Total Liabilities
34.5M
↑ 0.0%
FY19Y/Y Change
Operating Cash Flow
-1.2M
-
Investing Cash Flow
-1.7M
-
Financing Cash Flow
6.5M
-
FY20Y/Y Change
Operating Cash Flow
-4.2M
↑ 248.68%
Investing Cash Flow
-1.5M
↓ 12.47%
Financing Cash Flow
2.8M
↓ 56.39%
FY21Y/Y Change
Operating Cash Flow
2.9M
↓ 170.58%
Investing Cash Flow
-1.3M
↓ 12.43%
Financing Cash Flow
12.0M
↑ 325.46%
FY22Y/Y Change
Operating Cash Flow
521.9K
↓ 82.25%
Investing Cash Flow
-11.6M
↑ 806.01%
Financing Cash Flow
3.7M
↓ 69.14%
FY23Y/Y Change
Operating Cash Flow
517.7K
↓ 0.8%
Investing Cash Flow
-2.6M
↓ 77.81%
Financing Cash Flow
-285.3K
↓ 107.71%
Q1 FY23Q/Q Change
Operating Cash Flow
-71.6K
↓ 101.17%
Investing Cash Flow
-5.9M
↓ 200.08%
Financing Cash Flow
2.6M
↓ 124.4%

Technicals Summary

Sell

Neutral

Buy

Upexi Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Upexi Inc
Upexi Inc
-30.94%
-74.81%
-92.01%
-97.42%
-97.42%
Alphabet Inc. - Class C Shares
Alphabet Inc. - Class C Shares
10.81%
4.78%
18.78%
19.34%
175.64%
Meta Platforms Inc
Meta Platforms Inc
17.45%
14.7%
86.23%
82.18%
229.66%
Doordash
Doordash
15.0%
4.77%
88.35%
-26.63%
-24.38%
Spotify Technology Sa
Spotify Technology Sa
14.29%
23.16%
136.74%
59.72%
224.21%
Alphabet Inc. - Class A Shares
Alphabet Inc. - Class A Shares
10.54%
4.97%
18.75%
18.33%
173.42%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Upexi Inc
Upexi Inc
NA
NA
NA
-9.8
-0.79
-0.09
NA
21.1
Alphabet Inc. - Class C Shares
Alphabet Inc. - Class C Shares
23.59
23.59
1.1
7.66
0.31
0.16
0.0
24.41
Meta Platforms Inc
Meta Platforms Inc
30.31
30.31
1.03
21.29
0.35
0.18
0.0
61.89
Doordash
Doordash
NA
NA
NA
-0.01
-0.06
-0.02
NA
17.34
Spotify Technology Sa
Spotify Technology Sa
148.15
148.15
NA
6.41
0.15
0.05
NA
21.21
Alphabet Inc. - Class A Shares
Alphabet Inc. - Class A Shares
23.55
23.55
1.1
7.66
0.31
0.16
0.0
24.41
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Upexi Inc
Upexi Inc
Sell
$2.7M
-97.42%
NA
-27.72%
Alphabet Inc. - Class C Shares
Alphabet Inc. - Class C Shares
Buy
$2.1T
175.64%
23.59
26.7%
Meta Platforms Inc
Meta Platforms Inc
Buy
$1.5T
229.66%
30.31
34.34%
Doordash
Doordash
Buy
$59.0B
-24.38%
NA
-4.24%
Spotify Technology Sa
Spotify Technology Sa
Buy
$76.1B
224.21%
148.15
3.22%
Alphabet Inc. - Class A Shares
Alphabet Inc. - Class A Shares
Buy
$2.1T
173.42%
23.55
26.7%

Insights on Upexi Inc

  • Decreasing Revenue

    Revenue is down for the last 4 quarters, 27.34M → 14.44M (in $), with an average decrease of 18.0% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -4.11M → -4.11M (in $), with an average increase of 0.0% per quarter

  • Vs SPOT

    In the last 1 year, Spotify Technology Sa has given 136.7% return, outperforming this stock by 228.7%

Institutional Holdings

  • Vanguard Group Inc

    1.40%
  • HighTower Advisors, LLC

    1.03%
  • Geode Capital Management, LLC

    0.44%
  • Renaissance Technologies Corp

    0.09%
  • State Street Corp

    0.08%
  • Northern Trust Corp

    0.08%

Company Information

we are a passionate group of hemp and health enthusiasts who believe in a better life for all. our goal is to transform the landscape of how hemp and vitamins are produced, bought, and sold, with each of our brands curated for individual consumer needs. within the hemp space, we offer tinctures and gummies featuring an array of cannabinoids, from cbd, cbn, cbg and more. each designed to help consumers support their specific health needs. in the vitamin/nutraceutical space, we formulate products with specific ingredients designed to help support weight management, pain relief, stress relief, anti-inflammatory, and overall health and wellness. all products are manufactured, produced, and fulfilled in house at a state of the art facility that allows us to guarantee the highest standard of quality. this same facility has made us a leader in wholesale and private label distribution for clients across multiple industries. we stand by our products which is why we offer our customers free

Organization
Upexi Inc
Employees
95
CEO
Mr. Allan J. Marshall
Industry
Miscellaneous

FAQs